View Author
cancer breast tumor patient expression breast cancer level protein study mirna sample tissue analysis therapy factor tamoxifen prognostic table fibroblast breast cancer patients response survival marker receptor tumor cells disease assay association value variant treatment status prognosis signature figure epithelial control 0.00 group twist foekens ja result blood carcinoma pathway sieuwert method number klijn jg foeken metastasi -01 metastatic inhibitor ratio adjuvant growth klf 6-sv breast tumors research concentration breast cancer res er-positive correlation gene expression metalloproteinase cell lines transcript stromal klijn timp 1 mrna mrna levels chapter section mutation tissue inhibitor meijer-van gelder model system adam -9
10 Most Recent Publications
|
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
(Article)
Mostert, B. Jiang, Y. Spoel, P. van der Ramírez-Moreno, R. Verhoef, C. IJzermans, J.N.M. Gratama, J-W. Foekens, J.A. Sleijfer, S. Martens, J.W.M. Sieuwerts, A.M. Wang, H. Bolt-de Vries, J. Biermann, K. Kraan, J. Lalmahomed, Z.S. Galen, A. van Weerd, V. de |
2013-07-01
|
|
KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival
(Article)
Hatami, R. Sieuwerts, A.M. Germain, D.P. Burstein, D. Kirschenbaum, A. DiFeo, A. Foekens, J.A. Narla, G. Izadmehr, S. Yao, Z. Qiao, R.F. Papa, L. Look, M.P. Smid, M. Ohlssen, J. Levine, A.C. |
2013-01-23
|
|
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes
(Article)
Riaz, M. Sieuwerts, A.M. Look, M.P. Timmermans, A.M. Smid, M. Foekens, J.A. Martens, J.W.M. |
2012-09-11
|
|
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes
(Article)
Riaz, M. Berns, P.M.J.J. Foekens, J.A. Martens, J.W.M. Sieuwerts, A.M. Ruigrok-Ritstier, K. Weerd, V. de Groenewoud, A. Uitterlinden, A.G. Look, M.P. Klijn, J.G.M. Sleijfer, S. |
2011-07-12
|
|
mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients
(Article)
Sieuwerts, A.M. Mostert, B. Kraan, J. Spoel, P. van der Ramírez-Moreno, R. Deurzen, C.H.M. van Smid, M. Yu, J.X. Jiang, J. Wang, Y. Gratama, J-W. Sleijfer, S. Bolt-de Vries, J. Foekens, J.A. Martens, J.W.M. Peeters, D. Jongh, F.E. de Stouthard, J.M.L. Dirix, L. Dam, P.A. van Galen, A. van Weerd, V. de |
2011-06-01
|
|
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes
(Article)
Nagel, J.H.A. Peeters, J. Klijn, J.G.M. Spek, P.J. van der Foekens, J.A. Martens, J.W.M. Schutte, M. Meijers-Heijboer, H. Smid, M. Sieuwerts, A.M. Wasielewski, M. Weerd, V. de Trapman-Jansen, A.M.A.C. Ouweland, A.M.W. van den Brüggenwirth, H.T. IJcken, W.F.J. van |
2011-05-26
|
|
Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146
(Article)
Mostert, B. Kraan, J. Sleijfer, S. Bolt-de Vries, J. Spoel, P. van der Sieuwerts, A.M. Schutte, M. Timmermans, A.M. Foekens, R. Martens, J.W.M. Gratama, J-W. |
2011-05-01
|
|
Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients
(Article)
Mostert, B. Sieuwerts, A.M. Martens, J.W.M. Sleijfer, S. |
2011-04-01
|
|
Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients
(Article)
Mostert, B. Sieuwerts, A.M. Martens, J.W.M. Sleijfer, S. |
2011-01-01
|
|
Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: An independent retrospective validation study
(Article)
Sieuwerts, A.M. Ansems, M. Look, M.P. Span, P.N. Weerd, V. de Galen, A. van Foekens, J.A. Adema, G.J. Martens, J.W.M. |
2010-12-01
|
